PBAC Public Summary Document - July 2013

Public Summary Documents relating to the July 2013 PBAC meeting.

• Afatinib, tablets, 20 mg, 30 mg, 40 mg and 50 mg, (as dimaleate) Giotrif® (first line)
• Afatinib, tablets, 20 mg, 30 mg, 40 mg and 50 mg, (as dimaleate) Giotrif® (second / third line)
• Aflibercept, injection, 4 mg/0.1 mL, Eylea®
• Aflibercept, solution for IV injection, 100 mg/4 mL and 200 mg/8 mL, Zaltrap®
• Alogliptin, tablets, 6.25 mg, 12.5 mg, 25 mg Nesina®
• Botulinum Toxin Type A, injection, 100 units/vial, Botox®
• Budesonide, foam enema, 2 mg, Budenofalk®
• Budesonide with eformoterol fumarate dihydrate, oral pressurised inhalation, 50 micrograms – 3 micrograms per dose, 100 micrograms – 3 micrograms per dose, 200 micrograms – 6 micrograms per dose, Symbicort Rapihaler®
• Canagliflozin, tablet, 100 mg and 300 mg, Invokana®
• Collagenase clostridium histolyticum, lyophilised powder for injection, 900 micrograms powder for injection, Xiaflex®
• Dabrafenib, capsules, 50 mg and 75 mg Tafinlar®
• Dapagliflozin, tablet, 10 mg, Forxiga®
• Denosumab, injection, 60 mg/mL, Prolia®
• Dimethyl Fumarate, capsules, 120 mg and 240 mg, Tecfidera®
• Eltrombopag tablets, 25 mg, 50 mg, 75 mg and 100 mg (as olamine), Revolade®
• Erlotinib, tablets, 25 mg, 100 mg, 150 mg (as hydrochloride), Tarceva®
• Everolimus, tablet, 5 mg and 10 mg, Afinitor®
• Ezetimibe and Atorvastatin, pack containing 30 tablets ezetimibe 10 mg, and 30 tablets atorvastatin (as calcium) 10 mg, 20 mg, 40 mg or 80 mg, Atozet® Composite Pack
• Fluticasone propionate with eformoterol fumarate, inhalation pressurised, 50 micrograms-5 micrograms per actuation, 125 micrograms-5 micrograms per actuation, 250 micrograms-10 micrograms per actuation, 120 actuations, Flutiform®
• Gefitinib, tablet, 250 mg, Iressa®
• Ivacaftor, tablet, 150 mg, Kalydeco®
• Levonorgestrel, intrauterine system, 13.5 mg, Jaydess®
• Linezolid, injection, 600 mg per 300 mL, tablet, 600 mg and powder for oral suspension, 20 mg per mL, Zyvox®
• Lisdexamfetamine, capsules, 30 mg, 50 mg, and 70 mg, Vyvanse®
• Nabiximols, oral spray, 10 mL (90 actuations of 100 microlitres), Sativex®
• Naproxen with Esomeprazole, tablet, 500 mg – 20 mg (as magnesium trihydrate), Vimovo® - Public Summary Document
• Naproxen with Esomeprazole, tablet, 500 mg – 20 mg (as magnesium trihydrate), Vimovo® - Independent Review
• Naproxen with Esomeprazole, tablet, 500 mg – 20 mg (as magnesium trihydrate), Vimovo® - Review Response
• Olmesartan medoxomil and amlodipine and hydrochlorothiazide 20/5/15.5 mg, 40/5/12.5 mg, 40/5/25 mg, 40/10/12.5 mg, 40/10/25 mg, Sevikar HCT®
• Pazopanib, film-coated tablets, 200 mg and 400 mg (as hydrochloride), Votrient®
• Quetiapine, tablets (modified release), 50 mg, 150 mg, 200 mg and 300 mg, Seroquel XR®
• Ruxolitinib, tablets, 5 mg, 15 mg and 20 mg, Jakavi®
• Teriflunomide, tablet, 14 mg, Aubagio ®
• Tocilizumab, solution for I.V. infusion, 80 mg in 4 mL, 200 mg in 10 mL and 400 mg in 20 mL, Actemra®
• Trastuzumab emtansine, injection, 100 mg and 160 mg, Kadcyla®
• Vildagliptin, tablet, 50 mg, Galvus®
• Vildagliptin with metformin, tablets, 50 mg-500 mg, 50 mg-850 mg and 50 mg-1,000 mg, Galvumet®